METASTATIC LUNG CANCER
Clinical trials for METASTATIC LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lung cancers: targeted drug shows promise
Disease control OngoingThis study tests a new drug called DS-1062a in about 100 people with advanced non-small cell lung cancer that has spread or cannot be removed by surgery. Participants must have already tried at least one but no more than three standard treatments. The drug is given every three we…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Precision radiation may extend time without cancer growth in Bone-Only metastases
Disease control OngoingThis study tests whether adding a high-dose, precise type of radiation called SBRT to standard treatments (like hormone therapy or chemotherapy) can delay cancer progression in people with solid tumors that have spread to 1 to 5 spots in the bones. It includes adults up to age 75…
Matched conditions: METASTATIC LUNG CANCER
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New pill shows promise against tough lung and brain cancers
Disease control OngoingThis study tests an experimental pill called BDTX-1535 for people with advanced non-small cell lung cancer or a type of brain tumor called glioblastoma that have certain genetic changes. The goal is to find the best dose and see if the drug can shrink tumors or slow their growth.…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated May 08, 2026 12:00 UTC